April 20, 2021

News Update

Live News Feed

AstraZeneca and Johnson & Johnson: U.S. factories to stop production of AstraZeneca vaccines

us-15-million-doses-of-johnson-_-johnson

Emergent BioSolutions, a pharmaceutical company operated by an emerging biotechnology company in the United States, originally produced both Johnson & Johnson and AstraZeneca coronavirus vaccines. A few weeks ago, factory employees mistakenly conflated the raw materials of the above two vaccines, and as many as 15 million doses of Johnson & Johnson vaccine were scrapped. (AFP)

Emergent BioSolutions, a pharmaceutical company operated by an emerging biotechnology company in the United States, originally produced both AstraZeneca and Johnson & Johnson coronavirus vaccines. A few weeks ago, factory employees mistakenly conflated the raw materials of the above two vaccines, and as many as 15 million doses of Johnson & Johnson vaccine were scrapped.

AstraZeneca and Johnson & Johnson

A human error occurred at a vaccine foundry in Baltimore which was producing AstraZeneca and Johnson & Johnson vaccine, USA a few weeks ago, resulting in the scrapping of approximately 15 million doses of coronavirus vaccines. On the 3rd of this month, the US government requested this factory to stop producing two types of COVID-19 vaccines at the same time. Instead, Johnson & Johnson will be responsible for the production of vaccines.

According to reports, Emergent BioSolutions, a pharmaceutical company operated by a US emerging biotechnology company, originally produced both Johnson & Johnson and AstraZeneca vaccines for coronavirus. A few weeks ago, factory employees mistakenly conflated the raw materials of the above two vaccines, and as many as 15 million doses of Johnson & Johnson vaccine were scrapped.

The New York Times reported that two federal government health officials said on Saturday (3rd) that the US Department of Health and Human Services required the plant to only produce Johnson & Johnson vaccines in the future to avoid making similar mistakes.

Johnson & Johnson subsequently said in a statement that it “is fully assuming responsibility for the production of COVID-19 vaccines at the Bayview plant of the emerging biotechnology company.” However, the company did not say whether it will take over the factory.

According to the “New York Times”, AstraZeneca will cooperate with the US government and address the production of vaccines. A spokesperson for Xinxing Biotech declined to comment on the matter.

As the United States has not yet approved the use of AstraZeneca vaccine, the AstraZeneca vaccine produced at this plant in Baltimore has not yet been put on the US market.

According to reports, only one dose of Johnson & Johnson’s coronal disease vaccine is required, and all Johnson & Johnson vaccines currently used in the United States are produced in the Netherlands. Johnson & Johnson originally planned to switch to this plant in Baltimore to produce vaccines from April, but the delivery of vaccines is currently affected.

Also Read:

%d bloggers like this: